StemCell Institute Inc.
JPX: 7096.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Takafumi Shimizu
- Employees
- 98
- Headquarters
- Tokyo, Japan
- IPO year
- 2021
- Market cap
- ¥7.4B
- Website
- https://www.stemcell.co.jp
Loading 7096…
Loading profile data…Frequently asked questions about 7096
What does StemCell Institute Inc. (7096.T) do?
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc....
Where does 7096.T trade?
StemCell Institute Inc. (7096.T) trades on the Tokyo Stock Exchange.
What sector is 7096.T in?
StemCell Institute Inc. (7096.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of StemCell Institute Inc.?
Takafumi Shimizu is the chief executive officer of StemCell Institute Inc. (7096.T).
Where is StemCell Institute Inc. headquartered?
StemCell Institute Inc. is headquartered in Japan.
Does 7096.T pay a dividend?
Yes — StemCell Institute Inc. (7096.T) paid a trailing twelve-month dividend of JPY 25.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 7096.T go public?
StemCell Institute Inc. (7096.T) completed its initial public offering in 2021.